Femoston Conti

Description

Femoston Conti: HRT for Managing Menopausal Symptoms

What is Femoston Conti?

Femoston Conti is a combined hormone replacement therapy (HRT) tablet used to relieve symptoms associated with menopause. It delivers two hormones — estradiol (a form of oestrogen) and dydrogesterone(a progestogen). Each tablet combined of a dose of hormones daily available in two strengths film-coated tablets, used to relieve menopausal symptoms in postmenopausal women who have not had a period for at least 12 months

How Femoston Conti Works

Femoston Conti is a combined HRT, meaning both hormones are delivered without a break. This helps stabilise hormone levels and reduce menopausal symptoms.

Benefits of Femoston Conti

· Relief from vasomotor symptoms such as hot flashes and night sweats.

· Improved mood and sleep quality, often disrupted during menopause.

· Protection against bone loss, reducing the risk of osteoporosis.

· Reduced risk of endometrial hyperplasia (thickening of the uterine lining) compared with oestrogen-only therapy, thanks to the added progestogen.

Common Side Effects

Many users experience minor side effects that may fade over time as the body adjusts:

· Headache, nausea, or gastrointestinal changes such as diarrhoea

· Breast tenderness or pain

· Fatigue or mood changes

· Irregular bleeding or spotting during the early months of use

It is important to contact our healthcare professionals if side effects are severe, persistent, or concerning.

Risks and Serious Considerations

Although Femoston Conti is generally well tolerated, HRT carries some important risks that should be discussed with a clinician:

Potential Risks

· Breast cancer risk: Combined HRT may slightly increase the risk when used long-term.

· Blood clots: Oestrogen-containing HRT can increase the risk, especially in the first year.

· Stroke and heart disease: There may be a slight increased risk for certain users.

· Liver issues: Rare, but liver function should be monitored if symptoms appear.

Cautions and Contraindications

Femoston Conti should not be used if any of the following apply:

· Current, past, or suspected breast cancer or other oestrogen-dependent cancers

· Unexplained vaginal bleeding

· History of blood clots or clotting disorders

· Liver disease or impaired liver function

· Known or suspected porphyria (a rare blood disorder)

· Pregnancy or breastfeeding

Additionally, conditions such as gallstones, migraines, high blood pressure, diabetes, asthma, or a family history of hormone-related cancers may require careful monitoring.

Patient Information leaflet https://www.medicines.org.uk/emc/files/pil.1347.pdf